论文部分内容阅读
急性肾损伤(acute kidney injury,AKI)的早期诊断和预后评估标志物一直是肾脏病学、急症医学、检验医学及其他各相关学科非常关注的问题之一。随着分子生物学技术研究的不断深入及大型临床实验的不断开展,学者们提出用AKI代替传统急性肾衰竭(acute renal failure,ARF)的概念。
Early diagnosis and prognostic markers of acute kidney injury (AKI) have long been one of the major concerns in nephrology, acute medicine, laboratory medicine, and other related disciplines. With the deepening of molecular biological technology research and the continuous development of large-scale clinical trials, scholars have proposed using AKI instead of the traditional concept of acute renal failure (ARF).